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Dr Charles D. Fraser (Houston, Tex). I really congratulate Dr
Lee and colleagues for this important addition to our body of
knowledge concerning the long-term effects of TOF repair on
RV performance. This study really was beautifully presented,
and I congratulate you on the concise nature of your slides and
how clear and instructive they are.
From your original cohort of 251 patients undergoing TOF
repair, some by classic RV outflow tract incisions, some by the
transatrial/transpulmonary approach, 171 had complete MRI eval-
uations of RV performance at a mean of 15.5 years after the index
correction. In your multivariable analysis for factors associated
with late RV dilatation and dysfunction, you found male sex, inter-
val from the original operation, and pulmonary regurgitant fraction
to be independent predictors of an increased RVend-diastolic vol-
ume index. Of interest, residual RVOTO appears to be protective
against RV dilatation and dysfunction.
My questions, first, the goal of the study was to provide addi-
tional insight into the treatment of these patients. Based on that
premise, how has your thinking now evolved in terms of modifica-
tions you will make to the primary operation that you believe will
confer long-term protection to RV function?
Dr Lee. Thank you for your excellent comments and question,
Dr Fraser.
My institution is performing elective transatrial repair at 3 to 6
months of age for asymptomatic patients, and we prefer primary
repair for the younger symptomatic infants. From ours, and other
studies, I believe that leaving some degree of RVOTO will be pro-
tective against RV dilatation and dysfunction in the long term.
However, the optimal degree of RVOTO remains to be determined,
and our study could not answer this question. Moreover, it could be
difficult to target the optimal degree of RVOTO intraoperatively,
because we know that a tendency exists for a significant reduction
in the transpulmonary gradient postoperatively. Additional studies
are necessary to clarify this issue.
Dr Fraser. So, just to expand on that just a little bit, and I know
there will be some other questions, but you would tend to leave a
little more obstruction, be a little less liberal with your resection,
and, where possible, would you preserve the moderator band?The Journal of Thoracic and CarDr Lee. Yes, I think it is important to perform less resection of
the infundibulum, to leave some degree of RVOTO. In our study,
we found that the route of VSD closure was not an independent
factor for RV dilatation and dysfunction. Last year, at this meeting,
we presented rather disappointing results about limited RV inci-
sion in patients who underwent transannular repair. However, the
findings of our study should not be interpreted as discouraging
the use of the transatrial/transpulmonary approach for TOF repair.
We still believe that transatrial/transpulmonary repair of TOF has
some role for better long-term outcomes.
Dr Fraser. Just 2 quick more questions then. Tell us your insti-
tutional protocol for choosing patients for PVR now. What
threshold do you use in terms of the interval from surgery, regur-
gitant fraction, end-diastolic volume, and so on?
Dr Lee. My institution is rather aggressive toward PVR. Defi-
nitely, we recommend PVR for patients with symptoms or exercise
intolerance. For the asymptomatic patients—can I go back—this is
our recent report about PVR in our center. In this study, the median
age at PVR was about 17 years, and we found that PVR should be
considered before the RV EDVI exceeded 163 mL/m2 or the RV
end-systolic volume index exceeded 80 mL/m2 to achieve postop-
erative normalization of the RV volumes and function. It is diffi-
cult to know whether achieving normal RV volumes and
function after PVR is absolutely necessary for better long-term
outcomes; however, until proved otherwise, we have trying to
not exceed these cutoff values for the asymptomatic patients.
However, in practice, it has not always been possible to do this.
Sometimes, our cardiologists perform echocardiography and find a
severely dilated right ventricle, then they perform theMRI and find
a severely, very severely dilated right ventricle, for example, an RV
EDVI of 200 mL/m2. For this patient, I think we would be oper-
ating too late.
Therefore, to incorporate these cutoff values into the clinical de-
cision-making process, we should know the course of RV dilata-
tion and dysfunction. Also, I think this can be done by
performing serial MRI examinations, and this is an important issue
for future studies to assist in refining the optimal timing of PVR.
Dr Fraser. One last question. I cannot resist. So, as those of us
who have been married as long as I have know, the male sex is
disadvantaged. Why is that so in patients with TOF?
Dr Lee. Our result about the male sex is in accordance with the
findings from some previous studies. For example, the Atlanta
group reported that male sex was a significant risk factor for a
shorter interval between pulmonary valve disruption and PVR.
However, it is difficult to ascertain whether true sex-specific differ-
ences exist in the RV response to chronic volume overload,
because previous studies have reported sex-specific differences
in normal RV volumes and function. If our study result is simply
a reflection of the sex-specific differences in normal RV volumes,
I think we should apply sex-specific criteria for prescribing PVR.
Female patients will experience relatively more severe RV dilata-
tion and dysfunction if we use unisex criteria for PVR, and,
certainly, this will be an area of future study.
DrHillel Laks (Los Angeles, Calif).Aquestion and a comment.
First of all, the sex difference could be related to the degree of
physical activity in the first 12 years of life, or 14 or 15 or 18 years
of life, and males might be much more active during this period
than females, but that is just speculation.diovascular Surgery c Volume 148, Number 6 2595
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DThe second point is, I think, it is very important when we talk
about MRIs of the right ventricle to differentiate between 2 por-
tions of the right ventricle. The right ventricle has a contractile
ejecting lower chamber and an outflow tract. It is not infrequent,
and we have seen this in our own institution, where a patient can
have a patch that was made transannular with a huge RVaneurysm
and pulmonary artery aneurysm. However, the actual contracting
chamber below it will not be dilated and will beworking extremely
well. The MRI personnel who perform these studies include the
infundibulum and this aneurysm as part of their volume and in
calculating the EF. So, depending on the technique used, you
can have an outsized volume and a lower EF in a patient whose
actual contractile chamber is still doing extremely well. We try
to differentiate that. If it is just the aneurysm issue, because a non-
treated pericardial patch was used and was made too large, that
does not mean the right ventricle is failing. I assume that in your
institution, with close to 80% TAPs, that the surgeons were
extremely careful not to make very large incisions down into the
right ventricle and not to use a patch that would expand and cause
that to explain your excellent results and the lack of differentiation.
So, I think that until the time comes when we start asking our
radiologists and cardiologists who do these calculations to sepa-
rate these 2 issues, we will not have a good idea on what is actually
happening to RV function, in contrast to global issues that are
frequently surgeon-related and technique-related.
Dr Lee. Thank you for your comments. I agree with your
opinion about the functioning RV trabecular portion and that2596 The Journal of Thoracic and Cardiovascular Surmeasuring the RV trabecular portion’s volume and function is
important. However, I heard from my radiologist that it was not al-
ways clear to divide the right ventricle into the trabecular and
infundibular portion. That is a problem.
Dr Christoper A. Caldarone (Toronto, Ontario, Canada).
Could I just ask, in your multivariable analysis, the RV EF ap-
peared to be associated with some improvement in the face of
RVOTO and the hazard ratio was 5.4. What are the units in that
hazard ratio? For example, is it expressed in some percentage of
change in the EF normalized by some change in the pressure
gradient?
Dr Lee. RVOTO was entered into the analysis as yes or no, the
presence or absence of RVOTO.
Dr Caldarone. Oh, I see. So, this is a binary association?
Dr Lee. Yes.
Dr Caldarone. So that would be an interesting relationship to
study. Rather than creating discrete intervals in the RV outflow
tract gradient, the use of this variable as a continuous variable
would be informative.
The other point to consider is an interaction term might be pre-
sent between RVOTO and the regurgitant fraction. A greater regur-
gitant fraction could be associated with a greater gradient.
However, perhaps a gradient is protective, exactly as you said.
But, I think those 2 terms really need to be examined carefully
for a potential interaction in confounding your analysis.
Dr Lee. We did not examine the relationship between RVOTO
and regurgitant fraction, so I cannot answer that question.gery c December 2014
